Royal Jelly's History: Ancient Use, Mixed Evidence

What Royal Jelly Actually Is

Royal jelly is a thick, nutrient-dense secretion produced by young worker honeybees from glands in their heads. Every bee larva is fed royal jelly for the first few days of life, but only the larvae selected to become queens continue receiving it exclusively — a diet that triggers dramatic developmental differences and gives queens a lifespan many times longer than worker bees.

Ancient Legend, Long Before Modern Science

Royal jelly holds a documented place in ancient Egyptian and Greek culture, where it was associated with vitality, beauty, and longevity — most famously in the enduring legend connecting it to Cleopatra's beauty regimen. Whether or not that specific story is historically verifiable, it reflects how far back organized apitherapy — the therapeutic use of bee products — actually goes.

When Science Started Testing the Legend

Modern apitherapy research began taking royal jelly seriously starting around the 1960s, as scientists started systematically studying bee products for antimicrobial, antioxidative, anti-aging, immunomodulatory, and other effects. Over the following decades, that research expanded to include metabolic health and, specifically, diabetes-related outcomes — an area where royal jelly's story gets genuinely more complicated than most marketing copy lets on.

The Honest Picture on Blood Sugar

This is where we want to be direct rather than cherry-pick studies. Some research is encouraging: preclinical studies in diabetic animal models have reported that royal jelly supplementation improved biochemical markers and reduced oxidative stress in the liver and pancreas, and some human research — including studies in women with type 2 diabetes — has reported reductions in fasting blood glucose and glycosylated hemoglobin (HbA1c), alongside increased insulin levels.

But that's not the whole picture. A systematic review and meta-analysis of randomized clinical trials on royal jelly found that, taken as a whole, it did not significantly improve markers of glycemia. In other words: individual studies have shown promising results, but when researchers pooled the higher-quality trial data together, the overall effect on blood sugar markers wasn't statistically convincing. That's a genuinely mixed evidence base, not a settled one.